Joshua Krieger

Harvard University - Business School (HBS)

Assistant Professor of Business Administration

Soldiers Field Road

Morgan 270C

Boston, MA 02163

United States

http://www.hbs.edu/faculty/Pages/profile.aspx?facid=951435

SCHOLARLY PAPERS

6

DOWNLOADS

788

SSRN CITATIONS
Rank 24,328

SSRN RANKINGS

Top 24,328

in Total Papers Citations

24

CROSSREF CITATIONS

15

Scholarly Papers (6)

1.
Downloads 342 (124,051)
Citation 11

Developing Novel Drugs

Number of pages: 124 Posted: 05 Jan 2018 Last Revised: 27 Apr 2020
Joshua Krieger, Danielle Li and Dimitris Papanikolaou
Harvard University - Business School (HBS), Massachusetts Institute of Technology (MIT) and Northwestern University - Kellogg School of Management - Department of Finance
Downloads 245 (173,994)
Citation 8

Abstract:

Loading...

Drug Development, Innovation, Research & Development

Missing Novelty in Drug Development

NBER Working Paper No. w24595
Number of pages: 115 Posted: 16 May 2018 Last Revised: 16 Mar 2022
Joshua Krieger, Danielle Li and Dimitris Papanikolaou
Harvard University - Business School (HBS), Massachusetts Institute of Technology (MIT) - Sloan School of Management and Northwestern University - Kellogg School of Management - Department of Finance
Downloads 97 (372,045)
Citation 2

Abstract:

Loading...

Find and Replace: R&D Investment Following the Erosion of Existing Products

Harvard Business School Entrepreneurial Management Working Paper No. 19-058
Number of pages: 59 Posted: 17 Sep 2018 Last Revised: 10 Sep 2021
Joshua Krieger, Xuelin Li and Richard T. Thakor
Harvard University - Business School (HBS), University of South Carolina - Darla Moore School of Business and University of Minnesota - Carlson School of Management
Downloads 266 (160,347)
Citation 3

Abstract:

Loading...

R&D Investments, Drug Development, Product Shocks, M&A, Biopharmaceutical Industry, FDA

Find and Replace: R&D Investment Following the Erosion of Existing Products

Management Science, Forthcoming
Number of pages: 59 Posted: 08 Oct 2021
Joshua Krieger, Xuelin Li and Richard T. Thakor
Harvard University - Business School (HBS), University of South Carolina - Darla Moore School of Business and University of Minnesota - Carlson School of Management
Downloads 45 (557,645)

Abstract:

Loading...

R&D Investments, Drug Development, Product Shocks, M&A, Biopharmaceutical Industry, FDA

3.

How Important is Editorial Gatekeeping? Evidence from Top Biomedical Journals

Harvard Business School Technology & Operations Mgt. Unit Working Paper No. 22-011, Harvard Business School Entrepreneurial Management Working Paper No. 22-011
Number of pages: 36 Posted: 12 Jul 2021 Last Revised: 09 Sep 2021
Joshua Krieger, Kyle Myers and Ariel Dora Stern
Harvard University - Business School (HBS), Harvard University - Technology & Operations Management Unit and Harvard Business School
Downloads 78 (420,989)

Abstract:

Loading...

4.

Retractions

NBER Working Paper No. w18499
Number of pages: 63 Posted: 27 Oct 2012 Last Revised: 20 Jul 2022
Massachusetts Institute of Technology (MIT) - Sloan School of Management, Boston University - Department of Strategy & Policy, Harvard University - Business School (HBS) and Massachusetts Institute of Technology (MIT) - Entrepreneurship Center
Downloads 32 (616,531)
Citation 1

Abstract:

Loading...

5.

The Career Effects of Scandal: Evidence from Scientific Retractions

NBER Working Paper No. w21146
Number of pages: 59 Posted: 11 May 2015 Last Revised: 13 Apr 2022
Pierre Azoulay, Alessandro Bonatti and Joshua Krieger
Massachusetts Institute of Technology (MIT) - Sloan School of Management, Massachusetts Institute of Technology (MIT) - Sloan School of Management and Harvard University - Business School (HBS)
Downloads 20 (700,981)
Citation 4

Abstract:

Loading...

6.

Private and Social Returns to R&D: Drug Development and Demographics

NBER Working Paper No. w28355
Number of pages: 15 Posted: 19 Jan 2021 Last Revised: 24 Jun 2022
Downloads 5 (839,123)
  • Add to Cart

Abstract:

Loading...